CysLT(1) leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors

Montelukast and pranlukast are orally active leukotriene receptor antagonists selective for the CysLT(1) receptor. Conversely, the hP2Y(1,2,4,6,11,12,13,14) receptors represent a large family of GPCRs responding to either adenine or uracil nucleotides, or to sugar-nucleotides. Montelukast and pranlu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biochem Pharmacol
Autors principals: Mamedova, Liaman, Capra, Valérie, Accomazzo, Maria Rosa, Gao, Zhan-Guo, Ferrario, Silvia, Fumagalli, Marta, Abbracchio, Maria P., Rovati, G. Enrico, Jacobson, Kenneth A.
Format: Artigo
Idioma:Inglês
Publicat: 2005
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967539/
https://ncbi.nlm.nih.gov/pubmed/16280122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2005.10.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars